Robert Bruce's position in Fate Therapeutics is currently worth $1.56M. That's 0.53% of their equity portfolio (28th largest holding). The first Fate Therapeutics trade was made in Q4 2019. Since then Robert Bruce bought shares seven more times and sold shares on six occasions. The investor's estimated purchase price is $3.65M, resulting in a loss of 57%.